Loading...
The β-Lactams Strike Back: Ceftazidime-Avibactam
Gram-negative resistance has reached a crucial point, with emergence of pathogens resistant to most or all available antibiotics. Ceftazidime-avibactam is a newly approved agent combining ceftazidime and a novel β-lactamase inhibitor with activity against multidrug-resistant gram-negative bacteria....
Na minha lista:
| Udgivet i: | Pharmacotherapy |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4545577/ https://ncbi.nlm.nih.gov/pubmed/26289307 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/phar.1622 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|